Electroconvulsive Therapy as a Treatment for Somatization Disorder

Area of Science:

• Psychiatry
• Neurology
• Clinical Medicine

Background:

• Somatization disorder is a complex condition characterized by physical symptoms without a clear medical cause.
• Refractory cases pose significant challenges to clinicians, necessitating exploration of alternative treatment modalities.

Purpose of the Study:

• To systematically review the published literature from 2010-2020 on the efficacy of electroconvulsive therapy (ECT) for refractory somatization disorder.
• To assess the current evidence base for using ECT in managing severe and treatment-resistant somatization disorder.

Main Methods:

• A comprehensive literature search was performed across major databases (PsycInfo, MEDLINE, PubMed, Embase, Google Scholar) using relevant keywords.
• Included studies were limited to English-language articles published between 2010 and 2020, with a supplementary citation search conducted.
• Data were extracted and analyzed by both authors to synthesize findings related to ECT's effectiveness.

Main Results:

• The review identified limited evidence, comprising five single case studies, one case series, and one open trial.
• No controlled trials or systematic reviews were found, indicating low-quality evidence.
• The collated data suggest a potential benefit of ECT for severe, refractory somatization disorder.

Conclusions:

• Electroconvulsive therapy (ECT) shows promise as a treatment option for severe and refractory somatization disorder.
• Further high-quality research, including controlled trials, is essential to rigorously evaluate the efficacy, safety, and tolerability of ECT in this patient population.